Pulsed-Field Ablation: Proximity to Coronary Vessels and the Unresolved Issue of Induced Vasospasm

Pulsed-field ablation (PFA) has emerged as a promising technique in the treatment of atrial fibrillation, thanks to its ability to generate precise myocardial lesions with a superior safety profile compared to conventional ablation. It is a non-thermal method with greater tissue specificity.

Evolución de pacientes jóvenes con miocardiopatía hipertrófica tratados con ablación septal por alcoholización.

However, its extrapulmonary application—such as in the cavotricuspid isthmus (CTI) or the mitral isthmus (MI)—has raised concerns in early studies, given the possibility of coronary spasm due to the proximity of these structures to epicardial coronary vessels.

In this context, Tam et al. published an observational study that assessed, using OCT, the immediate and short-term structural changes in coronary arteries subjected to PFA.

Twenty-one patients treated with PFA for atrial flutter were included. Of them, 19 completed the imaging study series before, during, and three months after the procedure. As part of the protocol, nitroglycerin (NTG) was administered preventively in the corresponding arteries.

At three months, the ablation site showed significant increase in vascular wall area (WA), which rose from 2.69 mm² to 3.21 mm², equivalent to a 17.1-% remodeling (p <0.01). Additionally, the corrected lumen area (cLA) decreased from 6.92 mm² to 5.41 mm², accounting for a 10.1-% reduction (p <0.001).

Read also: TRIPLACE Registry: Conduction Disorders Following Transcatheter Tricuspid Valve Replacement.

These structural changes were not detected at remote reference sites, where the vascular wall remained relatively unchanged (ΔWA: 0.12 mm²; p = 0.926) and the corrected lumen area remained stable.

As for acute coronary spasm, it was documented in 75% of vessels (mild, 15%; moderate, 15%; severe, 45%). Acute lumen reduction showed a nonsignificant trend toward correlation with lumen loss at three months (r = 0.41, p = 0.08), suggesting a possible pathophysiological link between spasm and vascular remodeling.

Although, in terms of percentage, the structural modifications at three months are not striking (10.1% in corrected lumen area), their clinical impact could be relevant in patients with preexisting coronary artery disease, by altering the prognosis of intermediate or severe lesions.

Read also: Is It Useful to Index the Minimum Lumen Area to Ventricular Mass to Identify Functional Left Main Coronary Stenosis?

While there were no major short-term events—such as myocardial infarction or cardiovascular death—prolonged monitoring is essential, as the long-term clinical effect of these PFA-induced structural changes remains unknown.

Conclusions

Pulsed-field ablation for atrial flutter (CTI/MI), when applied in proximity to coronary arteries, may induce subclinical vascular remodeling, which justifies the need for prolonged follow-up in this population. This study was the first to demonstrate, quantitatively and through serial OCT, a potentially adverse impact.

Original Title: Effect of Pulsed-Field Ablation on Human Coronary Arteries. A Longitudinal Study With Intracoronary Imaging.

Reference: Tam MTK, Chan JYS, Chan CP, Wu EB, Lai A, Au ACK, Chi WK, Tan G, Yan BP. Effect of Pulsed-Field Ablation on Human Coronary Arteries: A Longitudinal Study With Intracoronary Imaging. JACC Clin Electrophysiol. 2025 Jul;11(7):1478-1488. doi: 10.1016/j.jacep.2025.03.014. Epub 2025 Apr 24. PMID: 40278817.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...